[Chronic hepatitis C in HIV-infected patients. Unfavorable interaction of HIV and HCV infection] NLM AIDSLINE Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[Chronic hepatitis C in HIV-infected patients. Unfavorable interaction of HIV and HCV infection]

MMW Fortschr Med. 2000 Mar 13;142 Suppl 1:60-2. Unique Identifier : AIDSLINE MED/20321537
Mauss S

Abstract: HIV coinfection promotes the progression of chronic hepatitis C. The increased hepatic mortality and improved life expectancy of HIV-positive patients warrants treatment of chronic hepatitis C in those infected with HIV. The treatment of hepatitis C considered standard for HIV-negative and, in principle, also for HIV-positive patients is the combination of interferon alpha with ribavirin. Possible interaction with the antiretroviral treatment by ribavirin must, however, taken into account. Although new therapeutic approaches are available, they have not yet been adequately validated terms of their efficacy and safety.

Keywords: JOURNAL ARTICLE Ungunstige Interaktion von HIV- und HCV-Infektion. Anti-HIV Agents/*ADMINISTRATION & DOSAGE/ADVERSE EFFECTS Antiviral Agents/*ADMINISTRATION & DOSAGE/ADVERSE EFFECTS AIDS-Related Opportunistic Infections/*DRUG THERAPY/MORTALITY Drug Therapy, Combination English Abstract Hepatitis C, Chronic/*DRUG THERAPY/MORTALITY Human HIV Infections/*DRUG THERAPY/MORTALITY Prognosis Survival Rate

KWDjournalarticleungunstigeinteraktionvonhiv-undhcv-infektionKWDanti-hivagents/KWDadministration&dosage/adverseeffectsantiviralagents/KWDadministration&dosage/adverseeffectsaids-relatedopportunisticinfections/KWDdrugtherapy/mortalitydrugtherapy,combinationenglishabstracthepatitisc,chronic/KWDdrugtherapy/mortalityhumanhivinfections/KWDdrugtherapy/mortalityprognosissurvivalrate
001130
A00B1135

Copyright © 2000 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .